Find a Tender
complete
Official procurement procedure
Insulin Pumps, Continuous Glucose Monitoring, Closed Loop Insulin Delivery Systems and Associated Products
Devices and instruments for transfusion and infusion
Industry specific software package
Infusion pumps
+1 more
UK
Published value
Not published
Submission deadline Not published
Lots published3
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: NHS Supply Chain Operated by DHL Supply Chain Limited acting as agent of Supply Chain Coordination Ltd (SCCL): "Insulin Pumps, Continuous Glucose Monitoring, Closed Loop Insulin Delivery Systems and Associated Products". Published status: complete. Published value: Value not published. 3 published lots. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | NHS Supply Chain Operated by DHL Supply Chain Limited acting as agent of Supply Chain Coordination Ltd (SCCL) | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: NHS Supply Chain Operated by DHL Supply Chain Limited acting as agent of Supply Chain Coordination Ltd (SCCL)
Market Analytics
Derived from OCDS awards & bid statistics
Published history for NHS Supply Chain Operated by DHL Supply Chain Limited acting as agent of Supply Chain Coordination Ltd (SCCL). These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Competition Density
12.6Bids / Report
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 30 active published awards; 30 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Procedure methodNot published | Procurement categoryNot published | |
Statuscomplete | Framework / DPSFramework | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published5 Jan 2022, 22:45 GMT | Last source update5 Jan 2022, 22:45 GMT | Recurring procurementNot published |
ClassificationDevices and instruments for transfusion and infusion, Industry specific software package, Infusion pumps, Infusion supplies | ||
Delivery area UK | ||
OCIDocds-h6vhtk-02bf24 | ||
What is being bought
This agreement is for the supply of Insulin Pumps, Continuous Glucose Monitoring (CGM) devices, Applications or software to enable the function of Closed Loop Insulin Delivery Systems and also for the dedicated consumables and accessories for the products listed above.
Precise quantities are unknown. It is anticipated that initial expenditure will be in the region of £15,000,000 - £20,000,000 in the first year year of this agreement, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement. Estimated total value over the 4 year agreement is approximately £75,000,000 to £100,000,000.
What changed
From the official release history
- tender value changed
5 Jan 2022, 22:45 GMT - Status changed to complete
5 Jan 2022, 22:45 GMT - Official notice release published
5 Jan 2022, 22:45 GMT - Submission deadline changed to published date
5 Jan 2022, 22:45 GMT - Buyer information updated
5 Jan 2022, 22:45 GMT - Published value updated to £100,000,000
22 Jun 2021, 22:45 BST - Status changed to active
22 Jun 2021, 22:45 BST - Official notice release published
22 Jun 2021, 22:45 BST - Submission deadline changed to 20 Jul 2021, 15:00 BST
22 Jun 2021, 22:45 BST - Buyer information updated
22 Jun 2021, 22:45 BST
Lots and requirements (3)
Published by the contracting authority
- Lot 1 · #1Insulin PumpscancelledPublished valueNot publishedThis lot is for Standalone Insulin Pumps and also Tethered Insulin Pumps, Patch Insulin Pumps, Tethered Pump with Integrated Continuous Glucose Monitor, Patch Pumps with Integrated Continuous Glucose Monitor, Tethered Pump with Integrated Continuous Glucose Monitor and Algorithm. This Lot also includes, but is not limited to; Insulin subcutaneous infusion set Tubes Cannula’s Needle cartridges Handsets Insertion Devices Adaptors Batteries Carry Cases Belts Remotes Sensors Finger Prickers Battery caps Resevoirs USB Adapters Clips Luer Locks Dressings Pouches Service packs Any other option or accessory used with or to configure the pumps Additional information: Anticipated expenditure will be circa £18,000,000 for the two years of this framework agreement, this is approximate and may vary depending on the requirements of bodies purchasing under the agreement. For the full 48 month term (if extended) the anticipated value is circa £36,000,000. These values are approximate, based on historical usage information, with a forecasted level of growth.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 2 · #2Continuous Glucose MonitorscancelledPublished valueNot publishedThis lot is for standalone CGM and Flash Glucose Monitoring. This Lot also includes Receivers, Transmitters, Sensors and Flash Glucose Monitoring Devices. This lot includes but is not limited to: Handsets Sensors Carry cases Tapes Finger prickers Clips Dressings Adhesives Insertion devices Testers Service Packs Download Features Any other option or accessory used to configure the unit Additional information: Anticipated expenditure will be circa £7,500,000 for the two years of this framework agreement, this is approximate and may vary depending on the requirements of bodies purchasing under the agreement. For the full 48 month term (if extended) the anticipated value is circa £14,500,000. These values are approximate, based on historical usage information, with a forecasted level of growth.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 3 · #3Software and Diabetes Management SystemscancelledPublished valueNot publishedThis lot is for Applications, Sortware or Alogrithms that contribute to the functionality of a Closed/Semi Closed Loop Insulin Delivery System and Diabetes Management Systems that allow for the uploading of information from Insulin Pumps, CGM’s, Glucose Meters and/or Mobile Applications. Mobile applications that act only as an Insulin Pump or CGM controller must not be included in this lot and must instead be submitted as an accessory in the relevant lot where the Pump or CGM device sits. Additional information: Anticipated expenditure will be circa £6,000,000 for the two years of this framework agreement, this is approximate and may vary depending on the requirements of bodies purchasing under the agreement. For the full 48 month term (if extended) the anticipated value is circa £12,000,000. These values are approximate, based on historical usage information, with a forecasted level of growth.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
5 Jan 2022, 22:45 GMT - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Contract active
Signed 19 Nov 2021, 00:00 GMT · £36,000,000 - Contract active
Signed 19 Nov 2021, 00:00 GMT · £14,500,000 - Contract active
Signed 19 Nov 2021, 00:00 GMT · £12,000,000
Commercial outcome and competition
Awards A.Menarini Diagnostics Ltd, Advanced Therapeutics (UK) Ltd, Air Liquide Healthcare Ltd, Insulet International Ltd, Medtronic Limited, Medtrum Ltd, ViCentra LTD, Worldlink Resources Limited, Ypsomed Ltd Not published · Not published · active A.Menarini Diagnostics Ltd, Abbott Laboratories Limited, Dexcom International Ltd, Medtronic Limited, Medtrum Ltd, Worldlink Resources Limited Not published · Not published · active A.Menarini Diagnostics Ltd, CamDiab Ltd, Glooko Limited, Medtronic Limited, Medtrum Ltd, Roche Diabetes Care Limited, ViCentra LTD, Wiliams Medical Supplies Limited, Ypsomed Ltd Not published · Not published · active |
Contracts Insulin Pumps £36,000,000 · signed 19 Nov 2021, 00:00 GMT · active Continuous Glucose Monitors £14,500,000 · signed 19 Nov 2021, 00:00 GMT · active Software and Diabetes Management Systems £12,000,000 · signed 19 Nov 2021, 00:00 GMT · active |
Bid statistics bids: 9 bids: 10 bids: 6 electronicBids: 10 electronicBids: 9 electronicBids: 6 foreignBidsFromEU: 1 foreignBidsFromEU: 1 foreignBidsFromNonEU: 9 foreignBidsFromNonEU: 8 foreignBidsFromNonEU: 6 smeBids: 6 smeBids: 6 smeBids: 2 |
Buyer and organisations in this procedure
NHS Supply Chain Operated by DHL Supply Chain Limited acting as agent of Supply Chain Coordination Ltd (SCCL)
Contracting authority GB-FTS-9249Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published